Figure 1: Arbitrary units (AU) of hybrid κ\λ antibody in study groups.

Arbitrary units (AU) of hybrid κ\λ antibody in patients with autoimmune pancreatitis (AIP, n = 61), acute pancreatitis (AP, n = 50), ordinary chronic pancreatitis (CP, n = 40), pancreatic cancer (Pca, n = 74), miscellaneous pancreatic diseases (MP, n = 15) and normal pancreas (NP, n = 98). Each horizontal bar represents the median value of serum hybrid κ\λ antibody in each study group. Significance: *P < 0.001 for AIP with respect to each non-AIP group, **P = 0.66 between groups of non-AIP.